Furanylfentanyl is a synthetic opioid primarily used in laboratory and forensic research settings due to its structural and pharmacological similarities to fentanyl. It plays a crucial role in the study of opioid receptor binding, metabolic breakdown, overdose modeling, and toxicological calibration. Researchers and forensic scientists use Furanylfentanyl to gain insights into emerging opioid analogs and their biochemical behavior in vitro, helping in the development of more accurate detection, treatment, and regulatory strategies.

• Opioid Receptor Binding Studies: Furanylfentanyl is a strong µ-opioid receptor agonist, making it ideal for evaluating the receptor binding affinity and potency of synthetic opioids. This helps in understanding the mechanisms of action behind opioid effects and overdose risk.

• Structure-Activity Relationship (SAR) Analysis: Due to its unique furan ring substitution, Furanylfentanyl is often studied alongside fentanyl and other analogs to assess how minor structural changes influence potency, receptor selectivity, and duration of action.

• Forensic Toxicology Research: It’s used as a reference standard to identify unknown substances in postmortem toxicology or drug seizure samples. Its presence in biological fluids such as blood or urine can be an indicator of synthetic opioid misuse.

• Metabolite Profiling: Furanylfentanyl’s metabolism is studied to map out how it’s broken down in the body, which is crucial for toxicological identification and forensic interpretation in suspected opioid-related fatalities.

• Analytical Method Development: Laboratories develop and refine LC-MS/MS or GC-MS protocols using Furanylfentanyl to improve sensitivity and specificity for detecting fentanyl analogs in complex biological matrices.

• Overdose Simulation Studies: Due to its high potency, Furanylfentanyl is used in modeling acute toxicity to study the thresholds at which synthetic opioids cause fatal respiratory depression.

The legality of Furanylfentanyl varies significantly depending on the jurisdiction. While some countries have explicitly scheduled it as a controlled substance, others classify it under analogue or blanket drug laws. Researchers must be aware of their local legal frameworks before ordering Furanylfentanyl from any supplier, including RC Plug.

• Scheduled in Certain Countries: Furanylfentanyl is classified as a Schedule I substance in the United States, making it illegal to possess, distribute, or research without a proper DEA license. Similar controls exist in Canada, the UK, and parts of the EU.

• Analog Laws May Apply: In jurisdictions without specific scheduling, Furanylfentanyl may fall under analogue laws, where substances structurally similar to controlled drugs are also treated as illegal under certain conditions.

• Research Exemptions Exist: Licensed laboratories and institutions may be allowed to study Furanylfentanyl under strict regulatory frameworks. These entities are typically required to submit detailed usage plans and secure facilities.

• RC Plug Disclaimer: While we do not require a prescription to purchase Furanylfentanyl, we strongly advise that buyers ensure compliance with their national, state, or regional laws. All sales are strictly for research purposes.

• Buyer Responsibility Clause: It is the sole responsibility of the customer to verify the legal status of Furanylfentanyl in their country before placing an order. RC Plug is not liable for customs seizures resulting from local legal restrictions.

• Shipping Restrictions Apply: We do not ship Furanylfentanyl to countries where it is explicitly banned or highly regulated. Orders placed from such regions may be canceled or redirected depending on applicable legal barriers.

Although Furanylfentanyl and fentanyl share a common chemical backbone, they differ structurally by a critical substitution: the introduction of a furan ring. This slight molecular modification significantly alters Furanylfentanyl’s pharmacological profile, receptor binding behavior, and metabolic pathway.

• Furan Ring Substitution: Furanylfentanyl contains a furan-2-carboxamide group in place of fentanyl’s traditional propionamide. This change alters its binding efficiency and duration of action.

• Receptor Affinity Variance: Furanylfentanyl tends to exhibit higher potency in µ-opioid receptor binding assays compared to fentanyl, though this can vary based on dosage and testing conditions.

• Lipophilicity and Absorption: The furan ring increases the compound’s lipophilicity, potentially enhancing membrane permeability and altering its onset of action when tested in vitro.

• Metabolic Pathways: Furanylfentanyl is broken down by liver enzymes into distinct metabolites compared to fentanyl, affecting how it’s detected in forensic drug screening.

• Duration and Intensity of Effect: While both compounds are short-acting, Furanylfentanyl may produce a quicker and more intense peak effect in lab simulations, followed by a sharp decline.

• Analytical Differentiation: Analytical instruments can distinguish Furanylfentanyl from fentanyl due to unique mass spectral fragmentation patterns and retention times on chromatography columns.

Furanylfentanyl is a highly potent research chemical and must be treated with extreme caution in laboratory environments. Even microgram-level exposure can pose serious health risks if not properly managed. Researchers should adhere to institutional safety guidelines and use appropriate lab-grade equipment when handling this substance.

• Use in a Controlled Environment: Always conduct experiments involving Furanylfentanyl inside a certified chemical fume hood to minimize the risk of inhalation exposure or aerosol formation.

• Personal Protective Equipment (PPE): Lab personnel should wear nitrile gloves, safety goggles, and a fitted respirator (or at minimum, a mask with a HEPA filter) during handling.

• Avoid Direct Skin Contact: Furanylfentanyl can be absorbed transdermally. Accidental contact, even in trace amounts, may lead to significant biological effects.

• Never Handle in Open Air: Powder or dust from Furanylfentanyl can become airborne easily. Handling it outside of enclosed systems increases exposure risk.

• Emergency Procedures: Labs should have naloxone (an opioid antagonist), first-aid kits, and spill management protocols in place when working with any fentanyl analogs.

• Labeling and Storage: Ensure containers are clearly labeled and stored in a secure, light-resistant location under 25°C to maintain chemical stability and prevent accidental misuse.

• Instrument Calibration: Use precision microbalances or analytical dispensers to avoid accidental overdosing during solution preparation or weight-based experiments.

No. Furanylfentanyl is not approved for human or veterinary use in any country. It exists solely for scientific and research-based applications and should not be consumed, administered, or otherwise applied to living organisms under any circumstance.

• Zero Therapeutic Approval: There are no registered medical indications or dosage guidelines for Furanylfentanyl. Regulatory bodies such as the FDA, EMA, and WHO classify it as a substance with high abuse potential and no medical utility.

• High Risk of Overdose: The compound’s extreme potency means even a slight miscalculation in exposure could result in respiratory depression or fatality.

• Not Suitable for Veterinary Use: Despite being structurally similar to some veterinary-grade opioids, Furanylfentanyl has never been approved or tested in animal care settings.

• RC Plug Restrictions: Our product is labeled and sold strictly for laboratory research. Any human or veterinary use would violate our terms of service and international regulations.

• Lack of Clinical Data: Furanylfentanyl has not undergone human clinical trials, meaning safety, pharmacokinetics, and side effects are not well-established or ethically verified.

• Ethical Compliance: Using Furanylfentanyl outside of controlled, non-clinical research constitutes an ethical and legal breach, potentially subject to criminal liability.

At RC Plug, we guarantee research-grade Furanylfentanyl with ≥98% purity. Every batch is independently tested using advanced analytical methods to ensure it meets the rigorous demands of modern laboratory and forensic research. Purity is a critical factor when working with potent synthetic opioids, as impurities or inconsistencies can compromise data integrity, result accuracy, or even pose safety hazards.

• Verified by GC/MS and HPLC: Each batch is analyzed using Gas Chromatography–Mass Spectrometry and High-Performance Liquid Chromatography. These industry-standard methods ensure that Furanylfentanyl is free from synthetic byproducts or undeclared analogs.

• ≥98% Laboratory-Grade Purity: We maintain a strict minimum of 98% purity to ensure our Furanylfentanyl is suitable for advanced chemical modeling, SAR studies, and forensic reference applications.

• Batch-Specific COA (Certificate of Analysis): With every shipment, we include a detailed COA that outlines the testing results, synthesis batch ID, and exact percentage of active compound.

• Zero Fillers or Additives: Our Furanylfentanyl is supplied in its pure form, free from any excipients, bulking agents, or stabilizers that could interfere with analytical accuracy.

• Analytical Consistency Across Batches: We work closely with a controlled, EU-based synthesis lab to ensure that each batch is consistent in potency, particle size, and chemical profile.

• Ideal for Calibration and Validation: Due to its purity, our Furanylfentanyl is frequently used as a standard in forensic labs for instrument calibration and method validation.

At RC Plug, we offer Furanylfentanyl in powder and crystalline forms, both of which are designed for precise scientific research. The choice of format can influence handling procedures, solubility, and compatibility with specific research protocols. Regardless of the form selected, our product is always lab-verified for chemical integrity and stability.

• Fine Powder: The powder form is ideal for creating solutions, dilutions, or applying to test substrates. It’s easily weighed, dissolves uniformly in compatible solvents, and is suitable for various chromatographic or receptor-binding experiments.

• Crystalline Form: Crystals offer improved long-term stability, are less prone to clumping from ambient moisture, and are often preferred for physical characterization studies like X-ray diffraction or melting point analysis.

• Packaged in Protective Vials: Both forms are sealed in airtight, moisture-resistant containers to preserve stability during transit and storage. This packaging also reduces contamination risks during lab handling.

• Identical Purity in All Formats: Whether you order Furanylfentanyl as a powder or in crystalline form, the chemical composition and purity are consistent across formats.

• Selected by Research Type: Crystalline Furanylfentanyl may be more appropriate for solid-state NMR studies or polymorphic analysis, while powder is favored for liquid chromatography and solubility testing.

• Custom Formats on Request: For institutional buyers with unique needs, we offer the option to request custom quantities or particle sizes (subject to availability and approval).

Proper storage of Furanylfentanyl is essential to maintain its potency, structural integrity, and safety profile. Like many synthetic opioids, Furanylfentanyl is sensitive to environmental conditions such as light, moisture, and heat. Researchers should follow standard chemical storage protocols to ensure the material remains stable for the full length of its shelf life.

• Store in a Cool, Dry Place: Ideal storage conditions are below 25°C (77°F), away from heat sources. Fluctuating temperatures can degrade the compound over time.

• Use Airtight Containers: Our products are packaged in tightly sealed containers, but once opened, researchers should reseal them immediately to prevent exposure to air and humidity.

• Avoid Direct Sunlight: Light exposure, particularly UV rays, can alter Furanylfentanyl’s chemical structure. Always store it in dark, shaded, or opaque containers.

• Label Clearly and Store Separately: To avoid cross-contamination, always store Furanylfentanyl in its original container, clearly labeled, and away from other research chemicals — particularly acids, oxidizers, and other opioids.

• Refrigeration Optional but Beneficial: Although refrigeration is not strictly necessary, storing at 2–8°C can extend shelf life and further reduce degradation risks for long-term research projects.

• Do Not Freeze: Freezing can cause condensation when thawed, potentially affecting the chemical’s consistency and purity.

Furanylfentanyl is a vital tool in multiple branches of scientific and forensic research. Because of its structural similarity to fentanyl but distinct pharmacokinetics, it’s used to evaluate binding mechanisms, toxicity thresholds, and forensic detection strategies. It serves as a key reference material for scientists seeking to understand opioid analogs and their public health implications.

• Opioid Pharmacology: Researchers use Furanylfentanyl to study µ-opioid receptor activation, desensitization patterns, and downstream signaling cascades in cellular assays and molecular binding models.

• Forensic Toxicology: It is employed as a calibrant in mass spectrometry analysis for drug seizure investigations and postmortem toxicology screening of suspected synthetic opioid overdoses.

• SAR and Analog Comparison: Its structural modifications make it an ideal candidate for structure-activity relationship research. Scientists analyze how substitutions at specific molecular positions influence receptor affinity and potency.

• Metabolic and Enzymatic Studies: Furanylfentanyl is used to identify primary and secondary metabolites when exposed to liver microsomes, contributing to the development of detection protocols in clinical labs.

• Overdose Modeling and Public Health Research: Toxicologists use this compound to estimate lethal dose thresholds and help shape policies around synthetic opioid exposure.

• Analytical Chemistry and Instrument Validation: Labs use Furanylfentanyl as a standard to develop and validate sensitive detection methods, particularly for LC-MS/MS and GC-MS systems.

Furanylfentanyl may not be detected by routine immunoassay-based drug screens due to its structural difference from standard opioids. However, advanced analytical methods can reliably identify it in biological specimens. Laboratories conducting forensic or clinical toxicology testing often require targeted protocols to ensure accurate detection.

• Not Detected by Basic Immunoassays: Standard drug panels commonly used in clinical settings may miss Furanylfentanyl because these tests are designed for traditional opioids like morphine and codeine.

• LC-MS/MS Required for Confirmation: Liquid Chromatography–Tandem Mass Spectrometry is the preferred method for detecting Furanylfentanyl, offering high sensitivity and selectivity even at low concentrations.

• GC-MS Can Be Utilized: Gas Chromatography–Mass Spectrometry is also effective, particularly for analyzing solid residues or biological extracts, though sample preparation may vary.

• Custom Testing Panels Needed: Forensic labs often use expanded opioid panels that include a wide range of fentanyl analogs, including Furanylfentanyl, to enhance detection in overdose or drug seizure cases.

• Metabolite Identification is Key: Furanylfentanyl is metabolized into several unique compounds. Including these metabolites in screening assays improves the likelihood of detection post-consumption (in non-human models).

• Retention Time and Fragmentation Profiling: Detection is enhanced using unique chromatographic retention times and mass spectral signatures that differentiate Furanylfentanyl from fentanyl and other analogs.

Furanylfentanyl presents substantial risks due to its extreme potency and ease of absorption through skin or inhalation. This compound is not safe for any form of human or animal contact and should only be handled under strict laboratory controls. Exposure — even to minuscule quantities — can result in severe respiratory depression or fatal overdose. It is crucial for researchers to adopt safety-first protocols when working with this substance.

• High Toxicity at Microgram Levels: Furanylfentanyl is active at extremely low doses, meaning accidental exposure — even from a small amount of residue — can lead to overdose symptoms.

• Transdermal Absorption Risk: The compound can be absorbed through skin, especially in powder form, making gloves and other skin barriers essential during handling.

• Respiratory Depression Hazard: Inhalation of dust or aerosolized particles can lead to slowed breathing, hypoxia, or death. Fume hoods and HEPA-filtered respirators are mandatory in labs working with it.

• Lack of Human Tolerance Threshold: Because it has no approved medical use, there is no established “safe” exposure level for humans, increasing the danger of working without containment.

• Delayed Symptom Onset: Symptoms of opioid overdose may not be immediate. A researcher exposed may not realize the severity until respiratory function has already declined.

• Potential for Cross-Contamination: Without proper cleaning and separation of lab tools, Furanylfentanyl residue can contaminate other workspaces, increasing the risk of accidental contact.

• Legal and Institutional Liability: Unauthorized exposure or improper handling may result in violations of lab safety standards, loss of institutional licenses, or legal consequences in some jurisdictions.

Furanylfentanyl and Carfentanil are both highly potent fentanyl analogs, but their profiles differ significantly in terms of potency, applications, and risk levels. While Furanylfentanyl is already considered a powerful synthetic opioid, Carfentanil is exponentially more potent and is rarely used outside of highly specialized veterinary or military applications. Understanding the differences is crucial for choosing the right compound for specific research purposes.

• Potency Comparison: Carfentanil is approximately 100 times more potent than fentanyl, while Furanylfentanyl is roughly 1.5 times more potent. This makes Carfentanil vastly more dangerous to handle in research environments.

• Duration of Action: Carfentanil acts and dissipates more quickly, with an ultra-short onset and short half-life. Furanylfentanyl, while still short-acting, has a slightly longer effect curve in in-vitro models.

• Usage Context: Carfentanil is used in tranquilizing large animals like elephants and tigers; Furanylfentanyl is strictly used in laboratory and forensic settings for toxicology and SAR analysis.

• Safety Protocols: Due to its extreme potency, Carfentanil requires even stricter safety protocols and is often handled in microgram (µg) quantities. Furanylfentanyl, while dangerous, can be studied in slightly larger lab-scale quantities.

• Legal Classification: Both substances are widely controlled, but Carfentanil often falls under military-grade scheduling, while Furanylfentanyl is usually listed with other designer opioids under Schedule I in many countries.

• Metabolic Pathways: Both analogs undergo enzymatic breakdown, but their metabolites differ significantly, which affects how they are detected in biological samples.

Detecting Furanylfentanyl accurately requires advanced laboratory instrumentation due to its structural similarity with other synthetic opioids and the limitations of traditional drug screening panels. Specialized protocols have been developed to ensure precision and avoid cross-reactivity with other fentanyl analogs.

• LC-MS/MS (Liquid Chromatography–Tandem Mass Spectrometry): This is the gold standard method for detecting Furanylfentanyl. It provides highly accurate quantification and specificity, even at sub-nanogram levels.

• GC-MS (Gas Chromatography–Mass Spectrometry): Suitable for analyzing Furanylfentanyl in both solid-state and biological fluid extracts, GC-MS offers detailed mass fragmentation patterns for compound identification.

• High-Resolution Mass Spectrometry (HRMS): Laboratories use HRMS for metabolite identification and structural elucidation when investigating unknown analogs or designing new screening protocols.

• Retention Time Differentiation: Due to its unique structure, Furanylfentanyl has a specific chromatographic retention time that distinguishes it from fentanyl, acetylfentanyl, or other analogs in complex mixtures.

• Spectral Libraries: Forensic labs often maintain custom spectral libraries that include Furanylfentanyl profiles to ensure fast and accurate identification during casework analysis.

• Use of Deuterated Internal Standards: When developing quantitative assays, researchers often use deuterated Furanylfentanyl analogs to enhance the precision and reproducibility of their results.

Yes, Furanylfentanyl is chemically sensitive and can degrade over time if not stored under appropriate conditions. Degradation affects the compound’s purity, potency, and structural consistency, which in turn compromises research outcomes. Understanding its storage chemistry and degradation pathways is essential for researchers seeking long-term stability and reliable data.

• Heat-Induced Breakdown: Exposure to high temperatures can accelerate the decomposition of Furanylfentanyl, especially if stored near heat sources or under poor ventilation.

• UV Light Sensitivity: Ultraviolet radiation can alter the molecular structure of Furanylfentanyl, leading to photodegradation and reduction in active compound concentration.

• Moisture Exposure: As a hygroscopic compound, Furanylfentanyl can absorb moisture from the air, leading to clumping and potential hydrolysis reactions that affect potency.

• Oxidation Risk: Air exposure over time may cause oxidative degradation. Storing it in airtight, oxygen-limited containers significantly reduces this risk.

• Loss of Analytical Reliability: Even minor degradation can skew results in binding assays, chromatography, or toxicology studies, making it unsuitable for publication or validation.

• Expiration Guidelines: RC Plug recommends using Furanylfentanyl within 12 to 24 months of delivery, assuming optimal storage conditions are maintained.

Whether you need a license to buy Furanylfentanyl depends entirely on your country’s or region’s legal status of the compound. While RC Plug does not require a prescription, we strictly sell Furanylfentanyl for authorized research use only and advise all clients to comply with their local laws before ordering.

• Controlled Substance Status: In countries like the United States, Canada, Australia, and the UK, Furanylfentanyl is classified as a controlled substance, requiring government-issued licenses for legal purchase and research use.

• Analog and Blanket Laws: Some regions enforce analog laws that treat Furanylfentanyl as a controlled substance due to its similarity to fentanyl, even if it is not named specifically in their schedules.

• Institutional Licensing: Licensed research labs, universities, and forensic institutions can often obtain exemptions or formal research licenses to study Furanylfentanyl under regulated frameworks.

• RC Plug Purchase Policy: We do not require a prescription, but every buyer must agree to our Terms of Sale, which prohibit human use and affirm the buyer’s legal compliance.

• Customs and Border Laws: In some countries, purchasing without a license may lead to customs seizures, legal penalties, or blacklisting. We recommend verifying with local agencies before ordering.

• Buyer Responsibility Agreement: All purchases require customer acknowledgment that Furanylfentanyl will be used strictly for laboratory research in accordance with local legal guidelines.

Furanylfentanyl has no recognized therapeutic applications in any clinical or veterinary setting. Unlike some of its opioid relatives that have limited but approved medical uses (like fentanyl for pain management), Furanylfentanyl is strictly a research chemical. It has never undergone clinical trials for safety or efficacy in humans and has no place in any approved pharmacopoeia or formulary.

• Not Approved by Any Health Authority: Organizations such as the FDA, EMA, TGA, and WHO have not approved Furanylfentanyl for medical use due to its lack of safety data and extreme potency.

• No Clinical Trials Conducted: Unlike fentanyl, which has extensive human data, Furanylfentanyl has never been evaluated in clinical trials. This absence of research makes it unsuitable for therapeutic use.

• High Overdose Risk: The compound is associated with unpredictable pharmacokinetics and a narrow safety margin, which makes it extremely risky for any medical context.

• No Veterinary Use Cases: Furanylfentanyl has never been utilized in veterinary medicine, even for large animal sedation, where other potent opioids (like carfentanil) are used under controlled conditions.

• Lack of Dosing Guidelines: There are no standardized dosing protocols, contraindications, or drug interaction studies, making it impossible to manage in a clinical setting.

• Research-Only Designation: RC Plug and most reputable vendors clearly state that Furanylfentanyl is not for human or animal use, reinforcing its sole designation as a laboratory-grade chemical.